November 09, 2007

Merck agrees to settle U.S. products liability Vioxx cases

The law firms that comprise the Executive Committee of the Plaintiffs' Steering Committee of the federal multidistrict Vioxx litigation, as well as representatives of plaintiffs' counsel in state coordinated proceedings, have reached an agreement to resolve U.S. products liability Vioxx claims already filed against the company. Merck has set aside $4.85 billion to pay claims of U.S. plaintiffs who suffered myocardial infarctions or ischemic strokes.

Click here for futher detail about the Merck settlement.